Abstract Background There is a paucity of plasma-based biomarkers that prospectively segregate the outcome of patients with head and neck squamous-cell carcinoma (HNSCC) treated with chemoradiation therapy (CRT). Plasma extracellular vesicles (EVs) might be an alternative source for discovery of new specific markers present in patients with HNSCC. which could help to re-direct patient... https://www.nacrack.com/deal-alert-Dea-Eyewear-Jemma-deal-zone/